Independent fund research. Built on SEC filings.

How we research funds

Fund comparison

HREX vs. XLV: which is better?

Bottom line

HREX vs XLV: the short answer

HREX (SPDR MSCI International Real Estate Currency Hedged ETF) and XLV (State Street(R) Health Care Select Sector SPDR(R) ETF) are both etfs.

Updated Nov 19, 2026

HREX vs XLV side by side

HREXXLV
TypeETFETF
Fund familySPDR (State Street)SPDR (State Street)
CategoryReal EstateHealth Care Sector
Expense ratio—0.08%
Annual cost per $10k—$8
10-yr cost on $10k (prospectus)—$103
Max front loadNoneNone
12b-1 fee—0.02%
1-yr return—+14.5%
5-yr return (annualized)—+8.1%
10-yr return (annualized)—+9.8%
Best quarter—+14.5%
Worst quarter—−12.7%
Net assets (fund)—$40.6B
Number of holdings—65
Portfolio turnover—2%
Returns as of—Dec 31, 2025

Source: SEC Form N-PORT and fund prospectuses

Holdings overlap

HREX and XLV share none of their top holdings.

HREX top 10

    XLV top 10

    1. Eli Lilly & Co — 16.51%
    2. Johnson & Johnson — 10.64%
    3. AbbVie Inc — 7.74%
    4. UnitedHealth Group Inc — 6.57%
    5. Merck & Co Inc — 5.52%
    6. Amgen Inc — 3.40%
    7. Thermo Fisher Scientific Inc — 3.24%
    8. Abbott Laboratories — 2.75%
    9. Gilead Sciences Inc — 2.73%
    10. Intuitive Surgical Inc — 2.45%

    FAQ

    What is the difference between HREX and XLV?
    HREX (SPDR MSCI International Real Estate Currency Hedged ETF) and XLV (State Street(R) Health Care Select Sector SPDR(R) ETF) are both etfs.
    Should I own both HREX and XLV?
    Because their portfolios differ, owning both can add diversification — check how they fit your overall allocation.

    Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.